Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16339486rdf:typepubmed:Citationlld:pubmed
pubmed-article:16339486lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:16339486lifeskim:mentionsumls-concept:C1306889lld:lifeskim
pubmed-article:16339486lifeskim:mentionsumls-concept:C0134835lld:lifeskim
pubmed-article:16339486lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:16339486lifeskim:mentionsumls-concept:C1154393lld:lifeskim
pubmed-article:16339486lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:16339486lifeskim:mentionsumls-concept:C0442818lld:lifeskim
pubmed-article:16339486pubmed:issue1lld:pubmed
pubmed-article:16339486pubmed:dateCreated2006-1-6lld:pubmed
pubmed-article:16339486pubmed:abstractTextRaised levels of soluble P-selectin (sP-selectin) have been reported in the plasma of patients with vascular diseases; however, the functional importance of this ligand remains unclear. In this study we have examined a potential role for plasma sP-selectin in regulating neutrophil adhesion in patients with peripheral arterial occlusive disease (PAOD). Patients with PAOD had significantly higher levels of sP-selectin (mean+/-SD: 73.3+/-13.0 versus 16.7+/-6.4 ng/mL) and enhanced whole blood leukocyte adhesion to platelets under shear. To examine whether the raised sP-selectin levels can directly influence leukocyte adhesion, isolated neutrophils were incubated with plasma from PAOD patients before and after immunodepletion of sP-selectin. Neutrophil adhesion to fibrinogen increased 2-fold following incubation with PAOD plasma, which was abrogated on sP-selectin immunodepletion. We subsequently demonstrated that recombinant sP-selectin dose-dependently (75 to 250 ng/mL) increased leukocyte adhesion to fibrinogen and platelet monolayers. This increase was PSGL-1 and Src kinase-dependent and correlated with an increase in sP-selectin-mediated Mac-1 activation. sP-selectin-stimulated neutrophil adhesion to platelet monolayers was inversely correlated with shear, such that at low shear (50 s(-1)) a 92.7%+/-15.7 increase in adhesion was observed decreasing to 38.5%+/-11.9 at 150 s(-1) and 10.1%+/-7.4 at 300 s(-1). These studies suggest a potentially important role for sP-selectin in modulating neutrophil adhesion in patients with PAOD, particularly at sites of low shear, where it raises the possibility that raised plasma sP-selectin levels may enhance leukocyte recruitment to vascular injury and promote disease progression.lld:pubmed
pubmed-article:16339486pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16339486pubmed:languageenglld:pubmed
pubmed-article:16339486pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16339486pubmed:citationSubsetIMlld:pubmed
pubmed-article:16339486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16339486pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16339486pubmed:statusMEDLINElld:pubmed
pubmed-article:16339486pubmed:monthJanlld:pubmed
pubmed-article:16339486pubmed:issn1524-4571lld:pubmed
pubmed-article:16339486pubmed:authorpubmed-author:KulkarniSSlld:pubmed
pubmed-article:16339486pubmed:authorpubmed-author:KlingDDlld:pubmed
pubmed-article:16339486pubmed:authorpubmed-author:JacksonSSlld:pubmed
pubmed-article:16339486pubmed:authorpubmed-author:DartA MAMlld:pubmed
pubmed-article:16339486pubmed:authorpubmed-author:Chin-DustingJ...lld:pubmed
pubmed-article:16339486pubmed:authorpubmed-author:WoollardK JKJlld:pubmed
pubmed-article:16339486pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16339486pubmed:day6lld:pubmed
pubmed-article:16339486pubmed:volume98lld:pubmed
pubmed-article:16339486pubmed:ownerNLMlld:pubmed
pubmed-article:16339486pubmed:authorsCompleteYlld:pubmed
pubmed-article:16339486pubmed:pagination149-56lld:pubmed
pubmed-article:16339486pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:meshHeadingpubmed-meshheading:16339486...lld:pubmed
pubmed-article:16339486pubmed:year2006lld:pubmed
pubmed-article:16339486pubmed:articleTitleRaised plasma soluble P-selectin in peripheral arterial occlusive disease enhances leukocyte adhesion.lld:pubmed
pubmed-article:16339486pubmed:affiliationAlfred and Baker Medical Unit, Wynn Domain, Baker Heart Research Institute, Melbourne, Australia. Kevin.Woollard@baker.edu.aulld:pubmed
pubmed-article:16339486pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16339486pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16339486lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16339486lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16339486lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16339486lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16339486lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16339486lld:pubmed